AstraZeneca Pharma India Limited, a biopharmaceutical company, engages in manufacturing, distributing, and marketing of pharmaceutical products in India and internationally. It manufactures and sells cardiovascular disease, renal, and metabolism medicines under the CRESTOR, Forxiga, BRILINTA, Xigduo, and Seloken XL brand names; oncology medicines under the TAGRISSO, CALQUENCE, Lynparza, ENHERTU, IMFINZI, and Zoladex brand names; rare diseases medicines under the Koselugo brand name; and respiratory medicines under the Symbicort and Fasenra brand names. The company also offers medicines for diabetes and immunology diseases. It also provides clinical trial services. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.
Metrics to compare | ASTR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipASTRPeersSector | |
---|---|---|---|---|
P/E Ratio | 205.1x | 42.9x | −0.6x | |
PEG Ratio | −7.30 | 0.09 | 0.00 | |
Price/Book | 27.6x | 5.0x | 2.6x | |
Price / LTM Sales | 14.2x | 3.9x | 3.3x | |
Upside (Analyst Target) | - | 5.5% | 49.0% | |
Fair Value Upside | Unlock | −8.9% | 7.7% | Unlock |